NCT07637448
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Southern Medical University Nanfang Hospital Department of Oncology Guangzhou, Guangdong, China
Clinical trial condition
EGFR Activating Mutation
Explore clinical trials studying EGFR Activating Mutation. Study availability and eligibility vary by location and protocol.
20 public trials
8 recruiting studies
EGFR Activating Mutation trial results
NCT07348965
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
- Locations
-
- Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China
NCT05257967
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
NCT05948813
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +8 more
- Locations
-
- National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
NCT06363734
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Department of Thoracic Medical Oncology, Tianjin Medical University Cancer Hospital Tianjin, Tianjin Municipality, China
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Angers - CHU Angers, France
- Bayonne - CH Bayonne, France
- Boulogne - Ambroise Paré Boulogne, France
- Lyon - URCOT Bron, France
NCT05382728
- Conditions
- EGFR Activating Mutation, NSCLC
- Locations
-
- Hunan Provincial Tumor Hospital Changsha, Hunan, China
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
NCT05768490
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +8 more
- Locations
-
- Sun-Yat-Sen university Guangdong, Guangzhou, China
Enrolling by Invitation
Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
NCT06730477
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
- Union hospital, Tongji Medical college, Huazhong University of Science and Technology Wuhan, Hubei, China
Not Yet Recruiting
First-line Therapy With EGFR-TKI Combined With Trastuzumab Rezetecan for Advanced NSCLC Harboring EGFR Mutations Concomitant With HER2 Alterations
NCT07699952
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified